Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiran Vemuri

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|January 8, 2023
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic RatsDimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 22, 2013
Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approachBernard Le Foll, Abhiram Pushparaj, Yaroslaw Pryslawsky, et al.
Journal of Proteome Research|April 5, 2017
Binding Site Characterization of AM1336, a Novel Covalent Inverse Agonist at Human Cannabinoid 2 Receptor, Using Mass Spectrometric AnalysisSrikrishnan Mallipeddi, Simion Kreimer, Nikolai Zvonok, et al.
European Journal of Pharmacology|October 9, 2013
Diuretic effects of cannabinoid agonists in miceGirish R Chopda, V Kiran Vemuri, Rishi Sharma, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2018
Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal TransitRichard A Slivicki, Shahin A Saberi, Vishakh Iyer, et al.
Psychopharmacology|March 17, 2015
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonistSherrica Tai, Spyros P Nikas, Vidyanand G Shukla, et al.
British Journal of Pharmacology|August 15, 2019
In vitro determination of the efficacy of illicit synthetic cannabinoids at CB<sub>1</sub> receptorsShivani Sachdev, Kiran Vemuri, Samuel D Banister, et al.
Psychopharmacology|March 4, 2011
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in ratsTorbjörn U C Järbe, Brian J LeMay, V Kiran Vemuri, et al.
Psychopharmacology|April 29, 2014
CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in ratsKiri L Wills, Kiran Vemuri, Alana Kalmar, et al.
Medicina (Kaunas, Lithuania)|November 3, 2020
Effects of the CB1 Receptor Antagonists AM6545 and AM4113 on Insulin Resistance in a High-Fructose High-Salt Rat Model of Metabolic SyndromeBasma G Eid, Thikryat Neamatallah, Abeer Hanafy, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|January 8, 2023
Blockade of CB1 or Activation of CB2 Cannabinoid Receptors Is Differentially Efficacious in the Treatment of the Early Pathological Events in Streptozotocin-Induced Diabetic RatsDimitris Spyridakos, Niki Mastrodimou, Kiran Vemuri, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|October 22, 2013
Translational strategies for therapeutic development in nicotine addiction: rethinking the conventional bench to bedside approachBernard Le Foll, Abhiram Pushparaj, Yaroslaw Pryslawsky, et al.
Journal of Proteome Research|April 5, 2017
Binding Site Characterization of AM1336, a Novel Covalent Inverse Agonist at Human Cannabinoid 2 Receptor, Using Mass Spectrometric AnalysisSrikrishnan Mallipeddi, Simion Kreimer, Nikolai Zvonok, et al.
European Journal of Pharmacology|October 9, 2013
Diuretic effects of cannabinoid agonists in miceGirish R Chopda, V Kiran Vemuri, Rishi Sharma, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 3, 2018
Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal TransitRichard A Slivicki, Shahin A Saberi, Vishakh Iyer, et al.
Psychopharmacology|March 17, 2015
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonistSherrica Tai, Spyros P Nikas, Vidyanand G Shukla, et al.
British Journal of Pharmacology|August 15, 2019
In vitro determination of the efficacy of illicit synthetic cannabinoids at CB<sub>1</sub> receptorsShivani Sachdev, Kiran Vemuri, Samuel D Banister, et al.
Psychopharmacology|March 4, 2011
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in ratsTorbjörn U C Järbe, Brian J LeMay, V Kiran Vemuri, et al.
Psychopharmacology|April 29, 2014
CB1 antagonism: interference with affective properties of acute naloxone-precipitated morphine withdrawal in ratsKiri L Wills, Kiran Vemuri, Alana Kalmar, et al.
Medicina (Kaunas, Lithuania)|November 3, 2020
Effects of the CB1 Receptor Antagonists AM6545 and AM4113 on Insulin Resistance in a High-Fructose High-Salt Rat Model of Metabolic SyndromeBasma G Eid, Thikryat Neamatallah, Abeer Hanafy, et al.
Pageof 7